摘要
分支酸利用酶(CUE),如分支酸变位酶、邻氨基苯甲酸盐合成酶、分支酸丙酮酸盐裂解酶、4-氨基-4-脱氧分支酸合成酶、异分支酸合成酶和水杨酸合酶是分支酸转化为细菌的生存所必需的各种产品的主要来源。在人体中,这些酶的缺失危害以及它们在细菌生存和发挥毒力时的重要性,让它们成为合适的抗菌化合物的潜在靶标。此外,CUE有显著的结构相似性和类似的催化机制,一种抑制剂可影响多个酶。本文遵循CUE催化反应机制的调查研究和抑制剂的研发进展。发现许多与分支酸反应过渡状态的相似结构的活性物质。最近,高微摩尔和低微摩尔的抑制剂对异分支酸-丙酮酸盐裂合酶被确定,它们能有效对抗分支酸变位酶和水杨酸合成酶,且属于具有最好活性的抑制剂的最新报道。
关键词: 邻氨基苯甲酸盐合成酶,抗菌剂,支酸变位酶
Current Medicinal Chemistry
Title:Investigation of Potential Inhibitors of Chorismate-Utilizing Enzymes
Volume: 22 Issue: 11
Author(s): Marketa Svarcova, Martin Kratky and Jarmila Vinsova
Affiliation:
关键词: 邻氨基苯甲酸盐合成酶,抗菌剂,支酸变位酶
摘要: Chorismate-utilizing enzymes (CUE) such as chorismate mutase, anthranilate synthase, chorismate pyruvate-lyase, 4-amino-4-deoxychorismate synthase, isochorismate synthase and salicylate synthase are responsible for converting chorismate into various products necessary for the survival of bacteria. The absence of these enzymes in humans and their importance in the virulence and survival of bacteria make them suitable targets for potential antimicrobial compounds. Furthermore, the CUE have significant structural homology and similar catalytic mechanisms, enabling the strategy of affecting multiple enzymes with one single inhibitor. This review follows up the investigation of mechanisms of CUE-catalysed reactions and the concurrent development of CUE inhibitors. Many active compounds were found amongst the structures mimicking the transition state of chorismate during the reaction. Most recently, high nanomolar and low micromolar inhibitors against isochorismate-pyruvate lyase were identified, which were also effective against chorismate mutase and salicylate synthase and belong to the most active inhibitors reported up to date.
Export Options
About this article
Cite this article as:
Marketa Svarcova, Martin Kratky and Jarmila Vinsova , Investigation of Potential Inhibitors of Chorismate-Utilizing Enzymes, Current Medicinal Chemistry 2015; 22 (11) . https://dx.doi.org/10.2174/0929867322666150209152446
DOI https://dx.doi.org/10.2174/0929867322666150209152446 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
Call for Papers in Thematic Issues
Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.
The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more
Approaches to the Treatment of Chronic Inflammation
Chronic inflammation is a hallmark of numerous diseases, significantly impacting global health. Although chronic inflammation is a hot topic, not much has been written about approaches to its treatment. This thematic issue aims to showcase the latest advancements in chronic inflammation treatment and foster discussion on future directions in this ...read more
Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications
The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize ...read more
Chalcogen-modified nucleic acid analogues
Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for many years. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium, tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. The continuing interest in ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
EDITORIAL: Validation Techniques for Therapeutic Molecules in Drug Discovery
Current Topics in Medicinal Chemistry Nrf2/HO-1 Mediated Antioxidant Activities, Cytotoxicity Analysis and LCESI/ MS Profiling of Eulophia nuda L.
The Natural Products Journal Microwave-mediated Regiospecific Synthesis of Some Novel Annulated Spiro[indoline-3,1`-indolizin]-2-ones
Letters in Organic Chemistry Tofacitinib, an Oral Janus Kinase Inhibitor: Perspectives in Dermatology
Current Medicinal Chemistry Disseminated Tuberculosis in an Immunocompetent State: A Case Report
Infectious Disorders - Drug Targets The Combined Effect of Curcumin and Crocin on the Reduction of Inflammatory Responses in Arthritic Rats
Current Medicinal Chemistry Antibacterial Agents Targeting the Bacterial Cell Wall
Current Medicinal Chemistry A Review of Recent Advancements in Anti-tubercular Molecular Hybrids
Current Medicinal Chemistry A Comprehensive Review of Monoamine Oxidase-A Inhibitors in their Syntheses and Potencies
Combinatorial Chemistry & High Throughput Screening Structure and Functions of Bacterial Outer Membrane Protein A, A Potential Therapeutic Target for Bacterial Infection
Current Topics in Medicinal Chemistry Tools to Evaluate the Eco-efficiency of Analytical Methods in the Context of Green and White Analytical Chemistry: A Review
Current Pharmaceutical Design Design, Molecular Docking, Synthesis, Characterization and Biological Activities of Novel Thiazole Derivatives
Letters in Drug Design & Discovery Biomedical Application of Polymers: A Case Study of Non-CNS Drugs Becoming CNS Acting Drugs
Central Nervous System Agents in Medicinal Chemistry Synergistic Interplay of The Co-administration of Rifampin And Newly Developed Anti-TB Drug: Could It Be a Promising New Line of TB Therapy?
Combinatorial Chemistry & High Throughput Screening Optimization of Drug Safety Profile in Inflammatory Bowel Disease Through a Personalized Approach
Current Drug Targets Patent Selections
Recent Patents on Anti-Infective Drug Discovery Novel Antibacterial Strategies for Combating Bacterial Multidrug Resistance
Current Pharmaceutical Design Cell Wall Associated Factors of Mycobacterium tuberculosis as Major Virulence Determinants: Current Perspectives in Drugs Discovery and Design
Current Drug Targets Functional Characterization of Alr0765, A Hypothetical Protein from Anabaena PCC 7120 Involved in Cellular Energy Status Sensing, Iron Acquisition and Abiotic Stress Management in E. coli Using Molecular, Biochemical and Computational Approaches
Current Genomics Enoyl Reductases as Targets for the Development of Anti-Tubercular and Anti-Malarial Agents
Current Drug Targets